C4 Therapeutics (CCCC) Non-cash Items (2019 - 2022)

C4 Therapeutics' Non-cash Items history runs 4 years deep, the most recent figure standing at $1.7 million for Q1 2022.

• In Q1 2022, Non-cash Items rose 214.0% year-over-year to $1.7 million; the TTM figure through Mar 2022 stood at $1.7 million (up 214.0% YoY), while the FY2021 annual figure was $1.4 million, down 98.67% from the prior year.
• Non-cash Items was $1.7 million for Q1 2022 at C4 Therapeutics, up from $1.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $102.6 million in Q4 2020 to a low of $531248.0 in Q1 2021.
• Historically, Non-cash Items has averaged $15.6 million across 4 years, with a median of $1.5 million in 2021.
• The sharpest annual moves came in 2020 and 2021: Non-cash Items surged 2037.78% in 2020, then sank 98.67% in 2021.
• A 4-year view of Non-cash Items shows it stood at $4.8 million in 2019, then soared by 2037.78% to $102.6 million in 2020, then tumbled by 98.67% to $1.4 million in 2021, then grew by 22.43% to $1.7 million in 2022.
• The last three Non-cash Items figures came in at $1.7 million (Q1 2022), $1.4 million (Q4 2021), and $1.1 million (Q3 2021), per Business Quant data.